title: Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.
authors.forename: Federico
authors.initials: F
authors.lastname: Alberici
authors.forename: Alessandra
authors.initials: A
authors.lastname: Palmisano
authors.forename: Maria L
authors.initials: ML
authors.lastname: Urban
authors.forename: Federica
authors.initials: F
authors.lastname: Maritati
authors.forename: Elena
authors.initials: E
authors.lastname: Oliva
authors.forename: Lucio
authors.initials: L
authors.lastname: Manenti
authors.forename: Stefania
authors.initials: S
authors.lastname: Ferretti
authors.forename: Rocco
authors.initials: R
authors.lastname: Cobelli
authors.forename: Carlo
authors.initials: C
authors.lastname: Buzio
authors.forename: Augusto
authors.initials: A
authors.lastname: Vaglio
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007558:Italy / Q000453:epidemiology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D012185:Retroperitoneal Fibrosis / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D055815:Young Adult
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate
keywords: Fibroblasts; Methotrexate; Systemic vasculitis